Type
. Antibodies to tubulin in patients with parasitic infections. Clinical and experimental immunology. 1987;68(1):78-85.
Type
. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases. The American journal of pathology. 1987;127(1):27-37.
Type
. The relation between allergy and immunity in leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1987;55(1):116-39.
Type
. Stigmatized illnesses in Africa. Journal of the Royal Society of Health. 1987;107(1):23-5, 27.
Type
. Effects of a synthetic extract (thymopentin) on the immune system of lepromatous leprosy patients. Cytobios. 1987;52(210-211):167-73.
Type
. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy]. Zhonghua yi xue za zhi. 1987;67(1):1-3.
Type
. Use of all age data may change results of Hansen's disease study. Public health reports (Washington, D.C. : 1974) [Internet]. 1987;102(1):118. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1477713/pdf/pubhealthrep00179-0120.pdf
Type
. [Learning from leprosy: a look at immunology and the Third World]. Rivista dell'infermiere. 1986;5(4):248-53.
Type
. Regulation of cell-mediated immunity in lepromatous leprosy. Leprosy review [Internet]. 1986;57 Suppl 2:199-202. Available from: http://leprev.ilsl.br/pdfs/1986/v57s2/pdf/v57s2a24.pdf
Type
. Lepromin stimulates interleukin-2 production and interleukin-2 receptor expression in situ in lepromatous leprosy patients. Leprosy review [Internet]. 1986;57 Suppl 2:189-98. Available from: http://leprev.ilsl.br/pdfs/1986/v57s2/pdf/v57s2a23.pdf